Twitter round-up: Eric Topol’s neurology tweet on ADHD top tweet in February 2020

11 March 2020 (Last Updated June 22nd, 2020 13:49)
Twitter round-up: Eric Topol’s neurology tweet on ADHD top tweet in February 2020

Pharmaceutical Technology lists ten of the most popular tweets on neurology in February 2020, based on data from GlobalData’s Influencer Platform. The top tweets were chosen from influencers as tracked by GlobalData’s Influencer Platform, which is based on a scientific process that works on pre-defined parameters. Influencers are selected after a deep analysis of the influencer’s relevance, network strength, engagement, and leading discussions on new and emerging trends.

Top tweets on neurology in February 2020

1. Eric Topol’s neurology tweet on a novel digital intervention for attention-deficit hyperactivity disorder

Eric Topol, a geneticist and scientist, shared an article to understand whether digital therapeutics can improve the attentional performance in children suffering with attention hyperactivity disorder (ADHD).

He added that digital therapeutics has proved to be effective in improving cognitive deficits related to the disorder. For example, the AKL-T01 is designed to target attention through an at-home play for 25 min every day, five days a week for four weeks. The article further stated that this digital intervention required further research, and could address many limitations associated with drug abuse, insurance coverage, and side effects.

Username: Eric Topol

Twitter handle: @EricTopol

Retweets: 127

Likes: 321

2. Ammar Al-Chalabi’s tweet on the need to develop a cure for ALS

Ammar Al-Chalabi, a consultant neurologist, shared an article on the need to develop a cure for amyotrophic lateral sclerosis (ALS). The article further revealed that one in 300 people were at a risk of developing the disease, which equals the risk of multiple sclerosis in the UK.

Also known as motor neuron disease (MND), studies have shown the disease to affect approximately 30,000 people in the US, with 5,000 cases added every year. Currently, there is no viable treatment or cure for the disease.

Username: Ammar Al-Chalabi

Twitter handle: @AmmarAlChalabi

Retweets: 52

Likes: 98

3. Nick Ward’s neurology tweet on pushing the limits of recovery in chronic stroke survivors

Nick Ward, a professor of clinical neurology and neurorehabilitation, shared an article on the Queen Square Upper Limb (QSUL) Neurorehabilitation Programme. A service provided by the National Health Service in the UK, the programme provides 90 hours of therapy for over three weeks to stroke survivors suffering with upper limb impairment. The study aimed at exploring the perceptions of the survivors, clinicians, and the carers.

Username: Nick Ward

Twitter handle: @dr_nickward

Retweets: 48

Likes: 74

4. Tom Pollak’s tweet on the association between influenza and schizophrenia

Tom Pollak, an adult psychiatrist, shared an article on the historical association between influenza and psychosis. The article stated that a number of ecological studies have already suggested that maternal influenza infection can increase the risk of psychosis in children.

Though there is no clear evidence of the genetic liability, the study does suggest that influenza infection can cause a number of effects during and after child birth. This, in turn, could lead to unexpected neurodevelopment courses, in the form of acute psychoses or schizophrenia.

Username: Tom Pollak

Twitter handle: @tompollak

Retweets: 36

Likes: 67

5. Amaal Starling’s tweet on dealing with the stigma of migraine

Amaal Starling, a neurologist at Mayo Clinic, Arizona, tweeted on migraine not being any one’s individual fault, but a genetic neurologic disorder. The influencer stated that migraine is the second major cause of disability across the world, and sufferers should not blame themselves for it.

Username: Amaal Starling

Twitter handle: @AmaalStarling

Retweets: 34

Likes: 75

6. Vaughan Bell’s tweet on UK ignoring the mental health crisis in Northern Ireland

Vaughan Bell, a neuropsychologist, shared an article on the situation in Northern Ireland, which receives the least mental health provisions by the UK mental health community. The influencer further noted that tackling suicide rates in Northern Ireland remained a priority for the Department of Health (DoH).

With the highest prevalence of mental health problems in the UK, people gathered in Stormont to protest for better mental health services in Northern Ireland.

Username: Vaughan Bell

Twitter handle: @vaughanbell

Retweets: 32

Likes: 63

7. Dorothy Bishop’s tweet on eugenics

Dorothy Bishop, a professor of developmental neuropsychology, tweeted that if humans were given a chance to select ‘good things’, as per the eugenics policy, they would choose tolerance. However, in such a case nobody would want such a policy.

She retweeted in response to Ian Birrell’s views, who noted that eugenics is about selecting good things. Likewise, intelligence is largely inherited and leads to better outcomes such as better health, and lower mental illnesses.

Username: Dorothy Bishop

Twitter handle: @deevybee

Retweets: 18

Likes: 80

8. GrowingUpAutistic’s tweet on dealing with autism

Libby, an autistic adult, tweeted on how challenging it is to work in busy and social environments. However, it is very rewarding, as she explains how she suffered from social anxiety and mutism as a kid, but now is happy and doing well at work.

Username: GrowingUpAutistic

Twitter handle: @LibbyAutism

Retweets: 12

Likes: 150

9. Gavin Giovannoni’s tweet on DMTs converting RRMS into PPMS or smouldering MS

Gavin Giovannoni, a neurologist, shared an article on how DMTs such as DMT pills or injections convert RRMS into PPMS, a condition where people have more advanced form of multiple sclerosis. The article further noted that as patients lose more reserve in this condition, the treatment response is less in PPMS and SPMS.

Username: GavinGiovannoni

Twitter handle: @GavinGiovannoni

Retweets: 12

Likes: 48

10. Dr Edward Wild’s tweet on the Tominersen drug for Huntington’s disease

Dr Edward Wild, a consultant neurologist, shared an article on the preliminary results of the 15-month old open-label extension (OLE) study. The analysis evaluated the long-term safety, tolerability and biomarker effects of Tominersen (RG6042) in participants. It was further found that the antisense drug designed to reduce the production of the huntingtin (HTT) protein in Huntington’s disease, was more suitable for chronic dosing paradigms.

Username: Dr Ed Wild

Twitter handle: @DrEdWild

Retweets: 11

Likes: 68